Investors

REDWOOD CITY, Calif., Nov. 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Piper Jaffray 24^th Annual Healthcare Conference at The New York Palace in New York, NY.  The presentation is scheduled for Tuesday, November 27, 2012 at 11:00 a.m. ET/8:00 a.m. PT.

SOURCE AcelRx Pharmaceuticals, Inc.

Jim Welch, Chief Financial Officer, +1-650-216-3511, jwelch@acelrx.com